首页 | 本学科首页   官方微博 | 高级检索  
     


Advanced glycosylation end products, protein kinase C and renal alterations in diabetic rats
Authors:RONG Jian  QIU Hongxin  WANO Shuping
Affiliation:1. Deuartmcnt of Endocnrinologv, Daping IIospltal of Thinl Military Medical University, Chongqing 400042, China
2. Dcpartment of Internal Medlciue, Fjrst .Affiliated Hospltal of Chongqing Univelstty of Medical .Seiences, Chongqing 400042, China
Abstract:Objective To study the relationship between advanced glycosylation end products (AGE) an d protein kinase C (PKC), and their effects on renal alteration in diabetic rats .Methods Insulin or aminoguanidine was administered to diabetic rats. Blood glucose, hem oglobin A(1C) (HbA(1C)), glomerular tissue extracts AGE (GTE-AGE), PKC, glomerular basement membrane thickness (GBMT) and urine protein/creatinine ( Pr/Cr) ratio in diabetic rats were measured and analysed. Results Levels of blood glucose, HbA(1C) and AGE, PKC activity, the Pr/Cr ratio an d GBMT were all significantly increased (P values all less than 0.01) in di abetic rats. Insulin could decrease the formation of HbA(1C) and AGE, and improve PKC activity. Aminoguanidine had no influence on PKC activity (P >0.05) although it decreased the formation of AGE. Both drugs could delay t he increase of urine Pr/Cr ratio and GBMT (P<0.05 or P<0.01). Conclusions Chronic hyperglycemia may lead to an increase of PKC activity. HbA(1C)and AGE may not directly contribute to alterations of PKC activity, but the increa se of PKC activity could promote the action of AGE on GBM thickening. It is imp ortant t o inhibit the formation of AGE and reduce the PKC activity so as to prevent or d elay the development of diabetic nephropathy.
Keywords:diabetic nephropathy    nonenzymatic glycosylation   protein kinase C    insulin    aminoguanidine advanced glycosylation end products    glomerular basement membrane
本文献已被 万方数据 等数据库收录!
点击此处可从《中华医学杂志(英文版)》浏览原始摘要信息
点击此处可从《中华医学杂志(英文版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号